East Africa
Multi-country region of eastern Africa; eight states targeted by ARILAC AMR laboratory capacity programme.
Last refreshed: 7 May 2026
Why is East Africa a priority geography for the EU's AMR laboratory investment?
Timeline for East Africa
Mentioned in: Africa CDC and EU launch ARILAC for AMR
Pandemics and BiosecurityMentioned in: Iran zone now spans Fujairah, Khorfakkan
Iran Conflict 2026Mentioned in: Migrant workers bear the Gulf's losses
Iran Conflict 2026- Which East African countries are part of the ARILAC AMR programme?
- Ethiopia, Uganda, and Mozambique are the East African states participating in ARILAC, the Africa CDC-EU four-year AMR laboratory capacity programme launched in Addis Ababa on 6 May 2026.Source: Africa CDC
- Why does East Africa have an antibiotic resistance problem?
- East Africa faces AMR driven by antibiotic overuse in both clinical settings, where prescribers often cannot access culture-and-sensitivity tests, and agricultural settings, where livestock antibiotic use goes largely unmonitored. Most clinical laboratories are equipped for HIV and malaria rapid tests, not bacterial resistance testing.Source: Africa CDC / KEMRI Wellcome
- What is KEMRI and how does it relate to East African AMR research?
- KEMRI (Kenya Medical Research Institute), run in partnership with the Wellcome Trust, is the primary East African research institution studying AMR and has consistently argued that clinical stewardship programmes are as important as laboratory capacity in the region.Source: KEMRI Wellcome Trust
Background
East Africa is a geographic region of the African continent broadly encompassing Kenya, Tanzania, Uganda, Rwanda, Burundi, Ethiopia, South Sudan, Somalia, Eritrea, Djibouti, and the island nations of Comoros, Madagascar, Mauritius, and Seychelles, though the precise boundaries vary by institutional and political context. The region includes both Rift Valley and coastal zones, is home to approximately 500 million people, and has some of the world's highest population growth rates. East Africa's health landscape includes a high burden of HIV, malaria, and tuberculosis as well as emerging concerns around zoonotic spillover, antimicrobial resistance, and neglected tropical diseases. Ethiopia, Uganda, and Kenya are regional health hubs with established national reference laboratories.
Three of the eight states in the ARILAC AMR laboratory capacity programme launched in Addis Ababa on 6 May 2026 are in East Africa: Ethiopia, Uganda, and Mozambique (counting Mozambique as East African by its Indian Ocean coastal orientation). East Africa's inclusion reflects the region's combination of significant agricultural antibiotic use, particularly in East African Rift Valley livestock systems, limited urban clinical laboratory capacity for culture-and-sensitivity testing, and the proximity of multiple ARILAC participant states to Kenya's KEMRI Wellcome Trust Research Programme, which provides a regional scientific anchor for One Health AMR research. The ARILAC programme's four-year One Health framework integrates human and veterinary AMR surveillance, directly relevant to the cross-border livestock corridors of the East African Rift.
